business.financialpost.com
Appili Therapeutics Announces FY 2019 Financial Results
HALIFAX, Nova Scotia — Appili Therapeutics Inc. (TSXV: APLI) (the “Company” or “Appili”), a biopharmaceutical company focused on anti-infective drug development, today…